Searched for
ANGIOZYME
- Actis Biologics starts phase-III trials of cancer drugBiotech firm Actis Biologics today said that Angiozyme, its biotech molecule targeted at colorectal cancer has entered into the third phase...
- Load More
Bengal BJP chief holds talks with Mumbai industry leaders, signals investment push
Food Processing Minister Chirag Paswan asks food cos to focus on making quality products
India's Godrej Consumer expects volume-driven first-quarter revenue rise
FDA issues compliance order for milk sector in Maharashtra; warns of Rs 10 lakh fine for violations
RBI imposes Rs 66.7 lakh penalty on Bank of Baroda, GIC Housing Finance
Ritabrata faction takes over TMC headquarters, escalates battle for party's political identity
Late kick-offs drag FIFA World Cup 2026 TV ad volumes down 14% in India
Maersk places order for 1,000 shipping containers with DCM Shriram Group
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service